title: Topical quinolone vs. antiseptic for treating chronic suppurative otitis media: a randomized controlled trial.
authors.affiliation: Internatinal Health Research Group, Liverpool School of Tropical Medicine, Liverpool, UK.
authors.forename: Carolyn
authors.initials: C
authors.lastname: Macfadyen
authors.forename: Carrol
authors.initials: C
authors.lastname: Gamble
authors.forename: Paul
authors.initials: P
authors.lastname: Garner
authors.forename: Isaac
authors.initials: I
authors.lastname: Macharia
authors.forename: Ian
authors.initials: I
authors.lastname: Mackenzie
authors.forename: Peter
authors.initials: P
authors.lastname: Mugwe
authors.forename: Herbert
authors.initials: H
authors.lastname: Oburra
authors.forename: Kennedy
authors.initials: K
authors.lastname: Otwombe
authors.forename: Stephen
authors.initials: S
authors.lastname: Taylor
authors.forename: Paula
authors.initials: P
authors.lastname: Williamson
mesh_terms: D000287:Administration, Topical; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D001309:Auditory Threshold / Q000502:physiology; D001888:Boric Acids / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D003906:Developing Countries; D006311:Hearing Disorders / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods; D010035:Otitis Media, Suppurative / Q000150:complications / Q000188:drug therapy* / Q000208:ethnology; D010146:Pain / Q000175:diagnosis / Q000209:etiology; D012720:Severity of Illness Index; D014432:Tympanic Membrane / Q000187:drug effects
chemical_list: D000890:Anti-Infective Agents; D001888:Boric Acids; D002939:Ciprofloxacin; C032688:boric acid